Varex Imaging Corporation (NASDAQ: VREX) is a Healthcare company (Medical - Devices) with a market capitalization of $769M. The Maz Rating grades it against the other companies in its sector.
Varex Imaging Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $18.10, Varex Imaging Corporation trades at 34.5x trailing earnings, 0.9x sales and 1.5x book value, with an EV/EBITDA of 11.1. Over the last twelve months it generated about $863M of revenue and $22M of net income. It runs a gross margin of 34.3%, an operating margin of 8.3% and a net margin of 2.6%. It shows return on equity of 4.6%, return on invested capital of 6.4% and a free cash flow yield of -2.6%. On the balance sheet: a debt-to-equity ratio of 0.75 and a current ratio of 3.38. Over the past 52 weeks the share price ranged from $9.09 to $18.63, with a beta of 1.03.
Varex Imaging Corporation does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 2 Buy and 5 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of July 2026, Varex Imaging Corporation (VREX) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 44.7% / 30% · (Cash+Inv) / Mkt Cap (36m) 15.4% / 30% · Interest income / Revenue 0.43% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 44.7% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 12.8% / 33% · Receivables / Mkt Cap (36m) 18.6% / 49% · Interest income / Revenue 0.43% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 44.7% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 12.8% / 33.33% · Receivables / Mkt Cap (24m) 18.6% / 33.33% · Interest income / Revenue 0.43% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 32.8% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 10.7% / 33.33% · Receivables / Avg Assets (4Q) 13.6% / 33.33% · Interest income / Revenue 0.43% / 5% | Pass |
| FTSE | Debt / Total Assets 31.6% / 33.33% · (Cash+ST Inv) / Total Assets 9.02% / 33.33% · (Cash+Recv) / Total Assets 22.2% / 33.33% · Interest income / Revenue 0.43% / 5% | Pass |
It depends on the standard you follow. As of July 2026, Varex Imaging Corporation (VREX) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
No. Varex Imaging Corporation is over the AAOIFI limit on Debt / Mkt Cap (36m).
About 0.43% of each dividend: Varex Imaging Corporation's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated July 3, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.